Refine by
Antibiotic Therapy Articles & Analysis
17 news found
Prostatitis is a disease characterized by the presence of inflammation and/or infection localized in the prostate gland. ...
Accelerate Diagnostics, Inc. is an in vitro diagnostics company dedicated to providing solutions for the global challenges of antibiotic resistance and sepsis. The Accelerate Pheno® system and Accelerate PhenoTest® BC kit combine several technologies aimed at reducing the time clinicians must wait to determine the most optimal antibiotic ...
208 patients enrolled in a prospective, randomized, controlled, multicenter, interventional trial Unyvero reduced the use of inappropriate antibiotic therapy by 45%, shortened inappropriate antibiotic therapy by 39 hours, and reduced overall antibiotic therapy duration by 22.5% Unyvero ...
The company has recently announced the launch of PCR-based microbial antibiotic resistance gene analysis service to help researchers develop new antimicrobial medicines to address the worldwide threat of antibiotic resistance. ...
Each year, more than 1.4 million patients with false-positive blood culture results are put at risk for sepsis misdiagnosis which can have serious impacts including unnecessary and prolonged antibiotic therapy, extended hospital stays, increased risk of hospital-acquired infections and increased morbidity and mortality. ...
This finding is significant as reducing inappropriate antibiotic therapy is the ultimate goal of reducing blood culture contamination. ...
All participants were ages 18 or older who had at least one recurrence after a primary episode of CDI and had completed at least one round of standard-of-care oral antibiotic therapy. According to a separate presentation on safety, RBX2660 demonstrated a consistent safety profile across all five clinical studies. ...
Specific Diagnostics today announced results from two studies conducted in the Paris Teaching Hospital System (Assistance Publique-Hôpitaux Paris, AP-HP), Europe’s largest hospital network, reporting performance of the Reveal rapid antibiotic susceptibility testing (AST) system. Both studies, which comprised approximately 225 samples in total, found the same levels of ...
Accelerate Diagnostics, Inc. is an in vitro diagnostics company dedicated to providing solutions for the global challenges of antibiotic resistance and sepsis. The Accelerate Pheno® system and Accelerate PhenoTest® BC kit combine several technologies aimed at reducing the time clinicians must wait to determine the most optimal antibiotic ...
As a result, middle ear infections are the #1 reason for antibiotic prescriptions and #1 reason for surgery in children. With the OtoNexus device, physicians can evaluate a middle ear infection and know whether antibiotic therapy is appropriate in less than 2 seconds. This definitive test will provide physicians the information they need to ...
As a result, middle ear infections are the #1 reason for antibiotic prescriptions and #1 reason for surgery in children. "Our goal is to decrease the usage of antibiotic therapy by 50% for the treatment of middle ear infections," said Caitlin Cameron, CEO OtoNexus Medical Technologies. ...
K192665, features improvements in susceptibility testing performance for four important antibiotics used to treat Pseudomonas aeruginosa, as well as the addition of the combination of P. aeruginosa and aztreonam, an empiric antibiotic, to the Accelerate PhenoTest BC kit testing panel. ...
These preliminary positive efficacy findings mark an important milestone, advancing RBX2660 in its clinical development program with a goal of bringing a US FDA approved therapy to patients. The clinical development program for RBX2660 is the most advanced in the world in evaluating the safety and efficacy of a standardized, non-antibiotic microbiome-based ...
Enrollment completion for the first Phase 3 clinical trial in microbiome industry Largest randomized, double-blinded study, with over 300 patients enrolled aimed to demonstrate the potential benefit of RBX2660 in reducing rates of recurrent Clostridioides difficile (C. diff) infection Rebiotix intends to use the results from the Phase 3 trial to serve as the basis for licensure application to ...
During this webinar listeners will learn the kinetics of PCT during infection, current biomarkers used in the management of bacterial infection, and how PCT can aid in antibiotic stewardship. Tuesday, September 24: We are sponsoring a webinar hosted by the Sepsis Alliance, "The Blind Spot of Antibiotic Stewardship: Antibiotic Overuse at ...
This would reduce mortality, prevent unnecessary hospitalization, and greatly reduce medical expenses. Because effective antibiotic therapy can immediately begin where appropriate, the risk of antibiotic resistance is also reduced. ...
Fever and chills that do not improve after antibiotic therapy are the most common symptoms. If the infection spreads to deep organs such as kidneys, liver, bones, muscles, joints, spleen, or eyes, additional specific symptoms may develop, which vary depending on the site of infection. ...